These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3924827)

  • 41. Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance.
    Blaser MJ; Smith PF; Repine JE; Joiner KA
    J Clin Invest; 1988 May; 81(5):1434-44. PubMed ID: 3366901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phagocytosis and intracellular killing of mucoid and nonmucoid variants of Pseudomonas aeruginosa by polymorphonuclear leukocytes: effect of specific immune sera.
    GoĊ›ciniak G; Maresz-Babczyszyn J; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1984; 32(4):467-79. PubMed ID: 6442852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.
    Peterson PK; Kim Y; Wilkinson BJ; Schmeling D; Michael AF; Quie PG
    Infect Immun; 1978 Jun; 20(3):770-5. PubMed ID: 352958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen.
    Clay CD; Soni S; Gunn JS; Schlesinger LS
    J Immunol; 2008 Oct; 181(8):5568-78. PubMed ID: 18832715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.
    Hatano K; Boisot S; DesJardins D; Wright DC; Brisker J; Pier GB
    Infect Immun; 1994 Sep; 62(9):3608-16. PubMed ID: 7520416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.
    Pier GB; Sidberry HF; Sadoff JC
    Infect Immun; 1981 Nov; 34(2):461-8. PubMed ID: 6171520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule.
    Hatano K; Goldberg JB; Pier GB
    J Bacteriol; 1993 Aug; 175(16):5117-28. PubMed ID: 7688717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of serotype-specific polysaccharide in the resistance of Streptococcus mutans to phagocytosis by human polymorphonuclear leukocytes.
    Tsuda H; Yamashita Y; Toyoshima K; Yamaguchi N; Oho T; Nakano Y; Nagata K; Koga T
    Infect Immun; 2000 Feb; 68(2):644-50. PubMed ID: 10639428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance of mucoid Pseudomonas aeruginosa to nonopsonic phagocytosis by alveolar macrophages in vitro.
    Krieg DP; Helmke RJ; German VF; Mangos JA
    Infect Immun; 1988 Dec; 56(12):3173-9. PubMed ID: 3141284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
    Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
    Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of the extracellular slime of Pseudomonas aeruginosa with antibody and complement (C).
    Gancevici G; Toporan M
    Arch Roum Pathol Exp Microbiol; 1983; 42(1):15-24. PubMed ID: 6443847
    [No Abstract]   [Full Text] [Related]  

  • 54. Polysaccharide antigens of Pseudomonas aeruginosa.
    Knirel YA
    Crit Rev Microbiol; 1990; 17(4):273-304. PubMed ID: 1698385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa.
    Pier GB; Thomas DM
    J Infect Dis; 1982 Feb; 145(2):217-23. PubMed ID: 6798136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
    Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
    Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    Horwitz MA; Silverstein SC
    J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The full expression of the ity phenotype in ityr mice requires C3 activation by Salmonella lipopolysaccharide.
    Nishikawa F; Yoshikawa S; Harada H; Kita M; Kita E
    Immunology; 1998 Dec; 95(4):640-7. PubMed ID: 9893057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.
    Tosi MF; Zakem H; Berger M
    J Clin Invest; 1990 Jul; 86(1):300-8. PubMed ID: 2164045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of antibodies in the opsonization of Yersinia spp.
    Tertti R; Eerola E; Granfors K; Lahesmaa-Rantala R; Pekkola-Heino K; Toivanen A
    Infect Immun; 1988 May; 56(5):1295-300. PubMed ID: 3281907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.